Menatetrenone

Spezifikationen

863-61-6CAS-Nummer

234-264-5EG-Nummer

2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dioneIUPAC-Name

C31H40O2Chemische Formel

444.6 g/molMolekulargewicht

menatetrenone; Menaquinone-4; 863-61-6; Menaquinone 4; Kaytwo; Menaquinone K4; vitamin K2(20); Menatetrenona; Vitamin MK 4; Menatetrenonum; Kaytwo n; MENATETRANONE; DTXSID6048969; 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione; 2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone; 2-Methyl-3-geranylgeranyl-1,4-naphthoquinone; 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthoquinone; 27Y876D139; DTXCID3028895; CHEBI:78277; 1,4-Naphthalenedione, 2-methyl-3-((2E,6E,10E)3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-; vitamin MK-4; 2-methyl-3-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)naphthalene-1,4-dione; (E,E,E)-isomer of menatetrenone; 2-Methyl-3-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-1,4-naphthoquinone; 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-1,4-naphthoquinone; 2-methyl-3-all-trans-tetraprenyl-1,4-naphthoquinone; RefChem:810913; E0167; vitamin K2; 11032-49-8; Kefton-2; Glakay; 2-Methyl-3-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)naphthalene-1,4-dione; MK-4; 6041-00-5; MFCD00079646; Menaquinone (K2); MLS000028742; C31H40O2; 6Z-Vitamin K2; SMR000058955; Menaquinone 4(Mixture of cis-trans isomers); 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-; Vitamin K2(sub 20); Menatetrenone [INN:JAN]; MK4; Menatetrenonum [INN-Latin]; K2(sub 20); Menatetrenona [INN-Spanish]; 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetrenyl)-1,4-naphthoquinone; Vitamin K1 Impurity 18; Vitamin K2(MK-4);Menaquinone K4; Menatetrenone-4; E3100; menaquinone(4); DKHGMERMDICWDU-GHDNBGIDSA-N; UNII-27Y876D139; NCGC00183125-01; 2-Methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthalene-1,4-dione; MK-4; Menatetrenone; Vitamin K2 (TN); Vitamin K2(MK-4); Opera_ID_148; 2-Methyl-3-tetraprenyl-1,4-naphthoquinone; Vitamin K2 (MK-4); Menadione sodium bisulfite;Vitamin K3 sodium bisulfite; Menaquinone-4 (Standard); 6Z-Vitamin K2(20); MENATETRENONE [INN]; MENATETRENONE [JAN]; Vitamin K2 pound MK-7); 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthochinon; DSSTox_CID_28895; DSSTox_RID_80857; Menatetrenone (JP18/INN); DSSTox_GSID_45406; MENAQUINONE 4 [MI]; 1,4-Naphthalenedione, 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-, (E,E,E)-; MENATETRENONE [MART.]; SCHEMBL434553; MENATETRENONE [WHO-DD]; CHEMBL259223; MQ-4; orb1220558; orb1305653; MENAQUINONE-4 [USP-RS]; SCHEMBL29362766; EX-A5474A; HY-B2156R; MSK1551; GLXC-21940; HMS2230J06; HMS5084D03; Ea-0167; HY-B2156; Tox21_110567; Tox21_113413; BDBM50423776; LMPR02030042; MSK160175; AKOS025311021; AKOS037645019; Menaquinone (K2), analytical standard; CCG-269176; DB12148; EBC-616110; FM25052; 2-Methyl-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-1,4-naphthalenedione; NCGC00181325-01; NCGC00181325-03; 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-1,4-dihydronaphthalene-1,4-dione; AS-17910; AS-56161; CAS-863-61-6; DA-75412; CS-0020307; M2398; NS00069524; T2336; T7106; 2-Methyl-3-geranylgeranyl-1,4-naphthoqui none; D00100; E-0167; T32373; Q192354; V344761; BRD-K75864342-001-14-2; 1,4-Naphthalenedione, 2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]-; 2-methyl-3-((2E6E10E)-371115-tetramethylhexadeca-261014-tetraen-1-yl)naphthalene-14-dione; 2-methyl-3-[(2E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-1,4-dihydronaphthalene-1,4-dione; Menatetrenone, 2-methyl-3-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)naphthalene-1,4-dioneSynonyme